...形成机制进行探讨,并以此为标准选择肿瘤坏死因子相关的凋亡诱导配体(tumor necrosis factor-related apoptosis-inducing ligand,TRAIL)作为逆转CAM-DR的工具,初步探讨其逆转CAM-DR的有效性及可行性,为从白血病骨髓微环境的角度探..
基于24个网页-相关网页
肿瘤坏死因子凋亡诱导配体(Tumor necrosis factor-related apoptosis-inducing ligand，TRAIL)是于1995年被克隆和命名的肿瘤坏死因子家族成员，TRAIL可特异性地诱导肿瘤细胞或者病毒感染细胞凋...
基于16个网页-相关网页
...关凋亡诱导配体 细胞增殖 [目的]研究肿瘤坏死因子相关凋亡诱导配体（tumor necrosis factor-related apoptosis-inducing ligand,TRAIL）对人肺腺癌细胞株Calu-3增殖和凋亡的影响。
基于4个网页-相关网页
...凋亡三者进行研究分析，结果发现用肿瘤坏死因 子相关的凋亡诱导配体（tumor necrosis factor-related apoptosis-inducing ligand,TRAIL）的增敏剂白藜芦醇 （resveratrol）诱导细胞发生的G1期阻滞时，survivin表 达降低且..
基于4个网页-相关网页
This study is to investigate the effect and its possible mechanisms of lidamycin (LDM) combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in human non-small cell lung cancer (NSCLC) cells.
研究力达霉素(LDM)与肿瘤坏死因子相关的凋亡诱导配体(TRAIL)联合作用对非小细胞肺癌细胞株H460细胞的增效作用及其作用机制。
参考来源 - 力达霉素联合TRAIL对非小细胞肺癌的协同作用及其机制·2,447,543篇论文数据，部分数据来源于NoteExpress
Aim: to investigate the relationship between the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), cell proliferation and apoptosis in children's skin hemangioma.
目的探讨小儿皮肤血管瘤各阶段肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达与细胞增殖和凋亡的关系。
Objective: To explore the role of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) combined with chemotherapeutic agents in treating neuroblastoma(NB) and the possible mechanism.
目的：探讨肿瘤坏死因子相关凋亡诱导配体（TRAIL）联合化疗药物治疗神经母细胞瘤（NB）的作用及其可能机制。
Objective to investigate the correlation between sensitivity to tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and expression level of death receptor 5 (DR5) on tumor cell surface.
目的探讨肿瘤细胞表面dr5表达水平与其对肿瘤坏死因子相关的凋亡诱导配体(TRAIL)敏感性之间的关系。
应用推荐